Your browser doesn't support javascript.
loading
Emerging phagocytosis checkpoints in cancer immunotherapy.
Liu, Yu'e; Wang, Yanjin; Yang, Yanrong; Weng, Linjun; Wu, Qi; Zhang, Jin; Zhao, Pengcheng; Fang, Lan; Shi, Yufeng; Wang, Ping.
Afiliación
  • Liu Y; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
  • Wang Y; Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Yang Y; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
  • Weng L; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
  • Wu Q; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
  • Zhang J; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, 39216, Jackson, MS, USA.
  • Zhao P; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
  • Fang L; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China. lanfang@tongji.edu.cn.
  • Shi Y; Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China. yshi@tongji.edu.cn.
  • Wang P; Clinical Center for Brain and Spinal Cord Research, Tongji University, Shanghai, 200092, China. yshi@tongji.edu.cn.
Signal Transduct Target Ther ; 8(1): 104, 2023 03 07.
Article en En | MEDLINE | ID: mdl-36882399

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno CD47 / Neoplasias Límite: Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno CD47 / Neoplasias Límite: Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Article País de afiliación: China
...